Connecticut Wealth Management »

Halozyme Therapeutics shares owned by Connecticut Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Connecticut Wealth Management from 13F filings

Historical chart of Connecticut Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Connecticut Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Connecticut Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $239k 5.9k 40.68
2023-12-31 $215k 5.8k 36.96
2023-09-30 $222k 5.8k 38.20
2023-06-30 $210k 5.8k 36.07

More positions owned by Connecticut Wealth Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Core Msci Emkt (IEMG)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Connecticut Wealth Management

Top funds holding Halozyme Therapeutics

Vanguard Group
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
TD Asset Management
Jennifer Ranahan
Dimensional Fund Advisors
Charles Schwab Investment Management
Arrowpoint Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Bank of America Corporation
New York State Common Retirement Fund

View all funds holding Halozyme Therapeutics